Acute aortic dissection
T Carrel, TM Sundt, Y von Kodolitsch, M Czerny - The Lancet, 2023 - thelancet.com
Although substantial progress has been made in the prevention, diagnosis, and treatment of
acute aortic dissection, it remains a complex cardiovascular event, with a high immediate …
acute aortic dissection, it remains a complex cardiovascular event, with a high immediate …
2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint …
Writing Committee Members, EM Isselbacher… - Journal of the American …, 2022 - jacc.org
Abstract Aim The “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic
Disease” provides recommendations to guide clinicians in the diagnosis, genetic evaluation …
Disease” provides recommendations to guide clinicians in the diagnosis, genetic evaluation …
Genetics and mechanisms of thoracic aortic disease
Aortic disease has many forms including aortic aneurysm and dissection, aortic coarctation
or abnormalities in aortic function, such as loss of aortic distensibility. Genetic analysis in …
or abnormalities in aortic function, such as loss of aortic distensibility. Genetic analysis in …
[PDF][PDF] 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …
M Brunström, M Burnier… - Journal of …, 2023 - docred-strapi-cms-prod.s3.sa-east-1 …
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
Distinct Mechanisms of β-Arrestin–Biased Agonist and Blocker of AT1R in Preventing Aortic Aneurysm and Associated Mortality
ZP Jara, TJ Harford, KD Singh, R Desnoyer… - …, 2023 - Am Heart Assoc
Background: Aortic aneurysm (AA) is a “silent killer” human disease with no effective
treatment. Although the therapeutic potential of various pharmacological agents have been …
treatment. Although the therapeutic potential of various pharmacological agents have been …
Efficacy and safety of sacubitril/valsartan in chronic Type B aortic dissection combined with mild hypertension
X Wang, F Song, L Jiang, Z Huang… - American Journal of …, 2024 - academic.oup.com
Background Optimal antihypertensive medication for chronic Type B aortic dissection
remains undecided. This study compared the efficacy and safety of sacubitril/valsartan with …
remains undecided. This study compared the efficacy and safety of sacubitril/valsartan with …
[HTML][HTML] 2022 ACC/AHA Guideline for the diagnosis and management of aortic disease
JA Beckman, WC Members - Journal of the American College of …, 2022 - ncbi.nlm.nih.gov
AIM The “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease”
provides recommendations to guide clinicians in the diagnosis, genetic evaluation and …
provides recommendations to guide clinicians in the diagnosis, genetic evaluation and …
Durability of biological valves implanted in aortic or mitral positions: a nationwide cohort study
CY Chen, CP Lin, KC Hung, YH Chan, VCC Wu… - The Annals of Thoracic …, 2023 - Elsevier
Background Biologic prostheses are being increasingly used for aortic and mitral valve
replacement (AVR and MVR). This study evaluated the long-term durability of bioprosthetic …
replacement (AVR and MVR). This study evaluated the long-term durability of bioprosthetic …
[HTML][HTML] Cardiovascular outcomes in kidney transplant recipients with ADPKD
M Chedid, HD Kaidbay, S Wigerinck… - Kidney International …, 2022 - Elsevier
Introduction Cardiovascular disease leads to high morbidity and mortality in patients with
kidney failure. Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a systemic …
kidney failure. Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a systemic …
[HTML][HTML] Evaluating prescription pattern and effectiveness of antihypertensive drugs in non-operated aortic dissection patients
YH Huang, KL Chiu, CW Shen, MJ Bair… - Journal of Clinical …, 2023 - mdpi.com
Introduction: Aortic dissection (AD) is a life-threatening disease. However, the effectiveness
of different strategies of antihypertensive therapies in non-operated AD patients is still …
of different strategies of antihypertensive therapies in non-operated AD patients is still …